Bifidobacterium infantis 35624 efficacy in patients with uncontrolled asthma: A randomized placebo-controlled trial

Ann Allergy Asthma Immunol. 2022 Dec;129(6):790-792. doi: 10.1016/j.anai.2022.08.1000. Epub 2022 Sep 9.
No abstract available

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Asthma* / therapy
  • Bifidobacterium
  • Bifidobacterium longum subspecies infantis
  • Double-Blind Method
  • Humans
  • Probiotics* / therapeutic use